Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Laven S.A. logo — LAVEN - Complementary Health Insurance. Access to personaliz...

Laven S.A.

LAVEN - Complementary Health Insurance. Access to personalized and innovative medicine in Poland.

Founded 2021 Poland Poland 12 employees Seed Total: $3.80M Insurance, Health insurance

General Information

Company Name Laven S.A.
Founded Year 2021
Location Poland Poland +1
Employees 12
Industries Insurance, Health insurance
Funding Stage Seed
Social

Get notified when Laven S.A. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Laven S.A.

Laven is a groundbreaking Poland-based startup that has made a mark in the insurance and health insurance industries with its pioneering offering. Founded in 2021, Laven has secured a significant PLN3.80M investment through a Seed Round led by 4growth VC on 10 April 2022, showcasing strong investor confidence in its potential. Laven's slogan "LAVEN - Complementary Health Insurance. Access to personalized and innovative medicine in Poland" captures the essence of its value proposition. The company provides a unique comprehensive health insurance solution in Poland, bridging the gap by offering coverage for drugs and medical devices not supported under the basic health care provided by the National Health Fund. Notably, it guarantees access to cutting-edge medical technologies, innovative drugs, and select medical devices, along with convenient treatment at premier centers in Poland, free from queues and extra charges. Furthermore, Laven's insurance policy encompasses the acquisition of drugs or medical devices, coordination of therapy using specific medical technologies, and the coverage of associated administration costs. In addition to these services, the startup offers access to medical e-consultations and remote Second Medical Opinions, allowing for professional medical advice and specialist treatment plans from leading global healthcare centers. Laven's innovative approach has positioned it as a trailblazer in providing tailored and progressive healthcare solutions, addressing unmet needs in the Polish market. With its recent investment injection, Laven is primed for further expansion and potential industry disruption, cementing its status as a standout player in the evolving health insurance landscape.

Taxonomy: health insurance, complementary health, innovative medicine, Poland healthcare, drug access, treatment coverage, e-consultation, remote consultation, personalized medicine, investment opportunities, telemedicine, healthcare accessibility

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
10 Apr 2022

Laven S.A. Alternatives & Competitors

Laven S.A. vs
HTA Consulting
HTA Consulting Poland

experience makes the difference

42 employees
Biopharma, Biotechnology
Laven S.A. vs
Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG
Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG Germany

„Im Mittelpunkt unserer Bemühungen steht der kranke Mensch“, unser Motto getreu dem Gründer Dr. Robe...

17 employees
Health Care
Laven S.A. vs
DIRECT2MD
DIRECT2MD United States

We are not Telemedicine. We are Totalmedicine.

8 employees
Health Care, Insurance

FAQ About Laven S.A.

LAVEN - Complementary Health Insurance. Access to personalized and innovative medicine in Poland.
Laven S.A. was founded in 2021.
Laven S.A. is headquartered in Poland.
Laven S.A. operates in the following industries: Insurance, Health insurance.
Laven S.A. has approximately 12 employees.
Laven S.A. has completed 1 funding round, raising a total of $3.80M. The latest funding stage is Seed.
Top alternatives and competitors to Laven S.A. include HTA Consulting, Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG, DIRECT2MD, Doctor Insta, UMP Healthcare 聯合醫務. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Laven S.A. and HTA Consulting are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Laven S.A. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy